Healthcare provider profile · identity verified

Crystal P Yeldell, MD

Family Practice · LANDOVER HILLS, MD · NPI 1366500985

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	678	232
Amlodipine Besylate	Amlodipine Besylate	506	177
Lisinopril	Lisinopril	277	88
Hydrochlorothiazide	Hydrochlorothiazide	255	84
Losartan Potassium	Losartan Potassium	244	87
Metformin Hcl	Metformin Hcl	188	66
Atenolol	Atenolol	154	56
Gabapentin	Gabapentin	132	48
Arexvy	Rsvpref3 Antigen/As01e/Pf	126	126
Glipizide	Glipizide	120	51
Levothyroxine Sodium	Levothyroxine Sodium	109	33
Meloxicam	Meloxicam	107	42
Furosemide	Furosemide	100	39
Simvastatin	Simvastatin	97	31
Hydralazine Hcl	Hydralazine Hcl	89	26
Pantoprazole Sodium	Pantoprazole Sodium	88	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	87	31
Metoprolol Tartrate	Metoprolol Tartrate	86	29
Albuterol Sulfate Hfa	Albuterol Sulfate	84	40
Potassium Chloride	Potassium Chloride	74	28
Metformin Hcl Er	Metformin Hcl	70	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	20
Lovastatin	Lovastatin	66	24
Pradaxa	Dabigatran Etexilate Mesylate	62	21
Famotidine	Famotidine	57	17
Tamsulosin Hcl	Tamsulosin Hcl	52	18
Humulin N Kwikpen	Insulin Nph Human Isophane	49	11
Clopidogrel	Clopidogrel Bisulfate	47	19
Ibuprofen	Ibuprofen	44	19
Jardiance	Empagliflozin	44	13
Wixela Inhub	Fluticasone Propion/Salmeterol	43	15
Eliquis	Apixaban	42	suppressed
Humulin N	Insulin Nph Human Isophane	42	11
Shingrix	Varicella-Zoster Ge/As01b/Pf	41	38
Trazodone Hcl	Trazodone Hcl	41	12
Clonidine Hcl	Clonidine Hcl	40	15
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	40	11
Spiriva Respimat	Tiotropium Bromide	39	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	38	12
Colchicine	Colchicine	37	14
Spironolactone	Spironolactone	37	13
Allopurinol	Allopurinol	36	14
Nifedipine Er	Nifedipine	35	12
Alendronate Sodium	Alendronate Sodium	32	11
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Alvesco	Ciclesonide	31	suppressed
Carvedilol	Carvedilol	30	suppressed
Humalog Kwikpen U-100	Insulin Lispro	30	suppressed
Metoprolol Succinate	Metoprolol Succinate	30	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Rosuvastatin Calcium	Rosuvastatin Calcium	26	12
Pregabalin	Pregabalin	25	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	24	suppressed
Xarelto	Rivaroxaban	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Fluocinonide	Fluocinonide	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Baclofen	Baclofen	17	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Naproxen	Naproxen	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Omeprazole	Omeprazole	14	suppressed
Topiramate	Topiramate	14	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Trospium Chloride Er	Trospium Chloride	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Prednisone	Prednisone	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error